Press Release | September 5, 2025
Entrada Therapeutics Announces Recipients of Third Annual DREAMS Grant Program
Read More
Press Release | September 2, 2025
Zenas BioPharma and Royalty Pharma Enter into Obexelimab Funding Agreement for up to $300 Million
Read More
Press Release | August 22, 2025
Kite to Acquire Interius BioTherapeutics to Advance In Vivo Platform
Read More
Press Release | August 19, 2025
āshibio Expands Clinical Pipeline with Vantictumab, a First-In-Class Antibody for Autosomal Dominant Osteopetrosis Type 2
Read More
